Skip to main content
OTLK filings

Corporate insider profile

Lawrence A Kenyon Filing Activity

Latest reported as Chief Financial Officer of Outlook Therapeutics, Inc. (OTLK).

Purchase filings
1
Reported companies
1
Net open-market value
$0.00
Latest transaction
Aug 14, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 14, 2026Outlook Therapeutics, Inc. (OTLK)Chief Financial OfficerOpen Market Purchase101,010$0.00$0.00